BRIEF published on 10/07/2024 at 09:50, 1 year 8 months ago Status of LNA Santé shares and voting rights as of September 30, 2024 Voting Rights Capital Actions Regulation Threshold Crossings
REGULATED PRESS RELEASE published on 10/07/2024 at 09:45, 1 year 8 months ago LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 30/09/2024 Société Générale déclare la répartition du capital et des droits de vote au 30/09/2024 conformément à l'article 223-16 de l'AMF. Informations indicatives Déclaration Société Générale Droits De Vote AMF Répartition De Capital
BRIEF published on 09/23/2024 at 18:07, 1 year 9 months ago LNA Santé : Mise à disposition du Rapport Financier Semestriel 2024 Actionnaires LNA Santé Rapport Financier Communiqué Semestriel 2024
BRIEF published on 09/23/2024 at 18:07, 1 year 9 months ago LNA Santé: Provision of the 2024 Half-Yearly Financial Report Shareholders Financial Report Press Release LNA Health Half-yearly 2024
REGULATED PRESS RELEASE published on 09/23/2024 at 18:02, 1 year 9 months ago LNA SANTE : Mise à disposition du Rapport Financier Semestriel 2024 LNA Santé met à disposition son rapport financier semestriel 2024 sur son site Web. Découvrez les résultats et présentations sur www.lna-sante.com Actionnaires LNA Santé Rapport Financier Site Web Semestriel
BRIEF published on 09/18/2024 at 19:19, 1 year 9 months ago LNA Santé Reports Steady Growth in H1 2024 Results Financial Results EBITDA LNA Santé Healthcare Growth H1 2024
BRIEF published on 09/18/2024 at 19:19, 1 year 9 months ago LNA Santé annonce une croissance soutenue de ses résultats au premier semestre 2024 Résultats Financiers EBITDA LNA Santé Croissance Des Soins De Santé Premier Semestre 2024
REGULATED PRESS RELEASE published on 09/18/2024 at 19:14, 1 year 9 months ago LNA SANTE : 2024 half-year results LNA Santé reports strong financial results for the 1st half of 2024, with operating sales of €386.3m and a net operating margin of 3.9%. Solid control of debt and confirmation of 2024 outlook Financial Results LNA Santé Operating Sales Net Operating Margin Debt Control
REGULATED PRESS RELEASE published on 09/18/2024 at 18:04, 1 year 9 months ago LNA SANTE : Résultats semestriels 2024
BRIEF published on 09/04/2024 at 11:21, 1 year 9 months ago Répartition de capital et des droits de vote chez LNA Santé au 31 août 2024 Autorité Des Marchés Financiers Capital LNA Santé Droits De Vote Actions
Published on 06/26/2026 at 01:40, 8 hours 16 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 10 hours 26 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 11 hours 26 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 12 hours 24 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 18 hours 26 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 09:43, 13 minutes ago ABO Energy secures wind energy tariffs and achieves further successes
Published on 06/26/2026 at 09:41, 15 minutes ago Emerald Horizon AG begins trading on the Vienna Stock Exchange
Published on 06/26/2026 at 09:26, 30 minutes ago Hamburg Direct Bank wins two German Brand Awards 2026
Published on 06/26/2026 at 09:25, 31 minutes ago SKYWORTH Solar Shines at Intersolar Europe 2026, Shaping the Future of Energy in Europe with a Comprehensive Product Matrix
Published on 06/26/2026 at 09:19, 36 minutes ago Zero Waste Foundation brought Türkiye’s COP31 vision to Bonn
Published on 06/26/2026 at 07:00, 2 hours 56 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 2 hours 56 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 15 hours 11 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 15 hours 26 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 16 hours 6 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
